WO2023210026A1 - Capteur - Google Patents
Capteur Download PDFInfo
- Publication number
- WO2023210026A1 WO2023210026A1 PCT/JP2022/020301 JP2022020301W WO2023210026A1 WO 2023210026 A1 WO2023210026 A1 WO 2023210026A1 JP 2022020301 W JP2022020301 W JP 2022020301W WO 2023210026 A1 WO2023210026 A1 WO 2023210026A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aptamer
- electrode
- pillar
- cells
- sensor
- Prior art date
Links
- 108091023037 Aptamer Proteins 0.000 claims abstract description 53
- 239000000758 substrate Substances 0.000 claims abstract description 24
- 239000002061 nanopillar Substances 0.000 claims description 20
- 239000004065 semiconductor Substances 0.000 claims description 6
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000003989 dielectric material Substances 0.000 claims description 4
- 108091008104 nucleic acid aptamers Proteins 0.000 claims description 4
- 108010079855 Peptide Aptamers Proteins 0.000 claims description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 3
- 239000003575 carbonaceous material Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 82
- 229920003209 poly(hydridosilsesquioxane) Polymers 0.000 description 16
- 238000002484 cyclic voltammetry Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 9
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 238000000329 molecular dynamics simulation Methods 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 230000005484 gravity Effects 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000005653 Brownian motion process Effects 0.000 description 4
- 108091008102 DNA aptamers Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005537 brownian motion Methods 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 238000000089 atomic force micrograph Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 230000005518 electrochemistry Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical compound CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000609 electron-beam lithography Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 239000002091 nanocage Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 238000001075 voltammogram Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/0656—Investigating concentration of particle suspensions using electric, e.g. electrostatic methods or magnetic methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/0606—Investigating concentration of particle suspensions by collecting particles on a support
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1023—Microstructural devices for non-optical measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
Definitions
- the present invention relates to sensor.
- Cancer is still one of the main pathologies with high probability of negative prognostic (death) in humans.
- CTCs rare circulating tumor cells
- electrochemical sensors are typically based on physical-chemical effects such as fluorescence, chemiluminescence, magnetic beads, calorimetry profiling or electrochemistry.
- electrochemical sensors provide attractive means for easy operation, high sensitivity, and portability. Additionally, they can benefit from ultimate scaling, either using redox-cycling or high-frequency signal amplification effects, as illustrated by the successful launch of ECsens startup for detecting individual biomarker particles specifically.
- the present invention has been made in view of the above problems, and an object of the present invention is to provide a redox-labelled sensor being able to improve signal to noise ratio.
- the present invention has been made based on the above findings, and the gist is as follows.
- a sensor comprising: a substrate; an electrode formed on at least a surface of the substrate; a pillar formed on a surface of the electrode; and an aptamer formed on the surface of the electrode, wherein a length of the aptamer in hairpin configuration is shorter than a height of the pillar in direction perpendicular to the surface of the electrode.
- aptamer is selected from the group consisting of a nucleic acid aptamer, a peptide aptamer, a protein aptamer, and a peptide nucleic acid.
- FIG. 1(a) is schematic representation of the sensor composed of nanopillars suspending non-target cells according to embodiment of the present invention.
- FIG. 1(b) is schematic representation of the sensor composed of nanopillars suspending target cells according to embodiment of the present invention.
- FIG. 1(c) is Atomic Force Microscope (AFM) image and cross section of the HSQ nanopillars according to Example of the present invention.
- AFM Atomic Force Microscope
- FIG. 1(d) is schematic representation of the Cyclic Voltammetry (CV/CVs) the embodiment of the present invention.
- FIG. 2(a) is graph showing results of CVs of a sensor measured until 14 days according to Example of the present invention.
- FIG. 2(b) is graph showing results of CVs of 10 different sensor with same fabrication condition according to Example of the present invention.
- FIG. 3(a) is graph showing AFM cross section and CV according to Example of the present invention.
- FIG. 3(b) is graph showing AFM cross section and CV according to Example of the present invention.
- FIG. 4 is figure showing schematic representation of the sensor and CVs according to Example of the present invention.
- FIG. 5(a) is graph showing CV according to Example of the present invention.
- FIG. 5(b) is graph showing CV peaks (I pe ak) plotted as a function of cells concentration according to Example of the present invention.
- FIG. 6(a) is graph showing hydrogen bonds energy estimated from MD simulation of tethered SYL3C aptamers without confinement, and under 5nm confinement according to Example of the present invention.
- FIG. 6(b) is graph showing I pea k plotted as a function of temperature for unconfined SYL3C, confined SYL3C with Ramos cells, and confined SYL3C with Capan-2 cells.
- FIG. 7 is graph showing results of stability test for CVs of the sensor with only Aptamer modified with Ferrocene (Apt-Fc) molecules obtained in 1.5 h according to Example of the present invention.
- FIG. 8 is fluorescent image to show the capan-2 cells clusters on the surface of our sensor after incubation according to Example of the present invention.
- FIG. 9(a) is graph showing CVs of Apt-Fc under confinement with Ramos cells according to Example of the present invention.
- FIG. 9(b) is graph showing CVs of Apt-Fc unconfmed according to Example of the present invention.
- FIG. 9(c) is graph showing CVs of Apt-Fc under confinement with Capan-2 cells according to Example of the present invention.
- FIG. 10 is images showing the cell concentration and cell size.
- Coupled and “connected”, which are utilized herein, are defined as follows.
- the term “connected” is used to describe a direct connection between two circuit elements, for example, by way of a metal line formed in accordance with normal integrated circuit fabrication techniques.
- the term “coupled” is used to describe either a direct connection or an indirect connection between two circuit elements.
- two coupled elements may be directly coupled by way of a metal line, or indirectly connected by way of an intervening circuit element (e.g., a capacitor, resistor, or by way of the source/drain terminals of a transistor).
- circuit means either a single component or a multiplicity of components, either active or passive, that are coupled together to provide a desired function.
- signal means at least one current, voltage, or data signal.
- the sensor 100 includes: a substrate 200; an electrode 300 being formed on at least a surface of the substrate 200; a pillar 400 being formed on a surface of the electrode 300; and a sensing element 500 formed on the surface of the electrode, and including an aptamer 510, wherein a length of the aptamer 510 is shorter than a height of the pillar 400 in direction perpendicular to the surface of the electrode 300.
- FIG. 1(a) is schematic representation of the sensor composed of nanopillars suspending non-target cell according to embodiment of the present invention.
- the sensor 100 includes the substrate 200.
- the substrate 100 at least has one surface (A).
- the substrate 100 may be plate shape or sheet shape.
- a material of the substrate 100 may be at least one or more selected from the group consisting of a dielectric material, a semiconductor material, and conductor material.
- the substrate 100 is semiconductor material.
- circuits can be from on the surface (A) of the substrate 100 and buried in the substrate 100. Thereby, the sensor 100 can be more compact.
- the substrate 100 may be flexible substrate 100.
- the sensor 100 includes the electrode 300.
- the electrode 300 is formed on the surface (A) of the substrate 200.
- the electrode 300 has one surface (A) that is different from a surface being in touch with the surface (B) of the substrate 200.
- the electrode 300 may be plate shape or sheet shape.
- the electrode 300 is one or more selected from the group consisting of a metal, a semiconductor, and a carbon material.
- the electrode 300 is Au.
- the sensor 100 includes the pillar 400.
- the pillar 400 is formed on the surface (B) of the electrode 300.
- the pillar 400 is for supporting a cell. Thereby, the pillar 400 ensures that the cell is too close with the sensing element 500. Thus, noise by cells gravity or cells stickiness can be further decreased. Therefore, signal to noise ratio can be further improved.
- the pillar 400 may include a surface being parallel to the surface of the electrode and being placed apart from the surface of the electrode 300.
- a pillar array may be form on the surface (B) of the electrode 300.
- the pillar array may be a regular array.
- a height of the pillar may be 5 nm to 40 nm. Thereby, noise by cells gravity or cells stickiness can be further decreased.
- the diameter between the pillars may be 200 nm or more. Thereby, penetration of pillars in the cell membrane can be avoided.
- the pillar may be made of a dielectric material.
- the pillar 400 is hydrogen-silsesquioxane (HSQ) nanopillars.
- the sensor 100 includes the sensing element 500.
- the sensing element 500 may include the aptamer 510, and a redox label 520.
- the sensing element 500 is formed on the surface (B) of the electrode 300. That is, the sensing element 500 is formed on the same surface of the electrode 300 as the pillar 400.
- the length of the aptamer 510 is shorter than the height of the pillar in direction perpendicular to the surface of the electrode.
- the aptamer 510 is oligonucleotide or peptide molecules that bind to a specific target molecule.
- the aptamer 510 can be one or more selected from the group consisting of a nucleic acid aptamer, a peptide aptamer, a protein aptamer, and a peptide nucleic acid.
- the nucleic acid aptamer can be a DNA aptamer or RNA aptamer.
- the aptamer 510 is DNA aptamer.
- the length of the aptamer 510 may be 10 nm to 30 nm.
- the redox label 520 may be attached to the aptamer 510.
- a type of the redox label 520 is not limited. In FIG. 1(a), the redox label 520 is ferrocene.
- the pillar 400 ensures that the cell is too close with the sensing element 500, noise by cells gravity or cells stickiness can be further decreased. Therefore, signal to noise ratio can be further improved.
- FIG. 1(a) is schematic representation of the sensor composed of nanopillars suspending non-target cells according to embodiment of the present invention. It is composed of: 1) a gold working electrode; 2) an active monolayer, composed of tethered Ferrocene (Fc)-labelled DNA aptamers (the experimentally identified SYL3C) deposited on a gold surface, for the recognition of the Epithelial Cell Adhesion Molecule (EpCAM), also including oligoethylene-glycol molecules (OEG) to avoid non-specific adsorption; and 3) a regular array of hydrogen-silsesquioxane (HSQ) nanopillars.
- the regular array of hydrogen-silsesquioxane (HSQ) nanopillars is fabricated by high-speed electron-beam (e-beam) lithography, used to improve the signal to noise ratio of e-DNA cytosensors.
- the HSQ solution is cross-linked to form a SiOx network structure after the exposure, which provides a chemically stable, flat, and biocompatible pattern.
- the diameter of 200 nm for the pillars has been chosen to avoid penetration of pillars in the cell membrane. Pillars pitch and height depend on cell deformation between pillars, and the length of the DNA aptamers dispersed on the surface between the pillars.
- the 500 nm pitch was chosen on the basis of a theoretical cell adhesion/deformation phase diagram as well as high yield fabrication process, as small pillar height requires a dense configuration.
- 1(c) presents the optimized nanopillars configuration with 200 nm diameter, 20 nm height and 500 nm pitch aiming to keep cells at a distance z sap of few nanometers above the surface, small enough to enable interaction of SYL3C aptamers with EpCAMs (FIG.1 (b)).
- FIGs. 1(a), and 1(b) depict how the aptamer Brownian motion affects the charge transfer between Fc and the electrode.
- Typical Cyclic Voltammetry (CV) curves are shown in FIG. 1(d).
- CV Cyclic Voltammetry
- the last tunable parameter is the pillars height that can be controlled precisely with HSQ.
- FIGs.3(a), 3(b) and 4(a) show CVs obtained for 7.1, 17.6 and 20 nm pillars height, respectively, while FIG.4(b) shows CVs without any pillars, both in the absence and presence of Ramos cells. While the CV peak (I pea k) is unaffected by the presence of Ramos cells for 20 nm thick pillars, I pea k is decreased with smaller pillar heights, suggesting that cells are “pushing” on the aptamer layer.
- FIG.6a shows the hydrogen bond energy histogram for tethered SYL3C at different temperatures in the absence/presence of a 5 nm confinement. This energy is related to the number of base pairs formed by the single-strand DNA, and therefore to the various hairpin configurations.
- the unconfined tethered SYL3C shows three main peaks at 20 °C, whereas only low energy peaks are observed above 40 °C, as expected from the 3 and 1-2 hairpins SYL3C configurations (FIG.6a).
- I pea k remains at its maximum value because all Fc, associated with aptamer Brownian motion in confined space, have a chance to exchange electrons to the bottom electrode. In other words, I pea k is only related to the number of aptamers on the surface. In contrast, I pea k decreases with temperature for unconfined SYL3C that can be associated with a decreased probability of electron transfer to the bottom electrode (the unconfined single-hairpin configuration extends Fc-surface distance).
- I pea k decreases substantially with the temperature in the presence of Capan-2 cells. This is related to the mechanism illustrated in FIG. lb with blocked electron transfer due to specific molecular recognition with aptamer folded DNA, Fc remaining close to the cell interface during recognition and cannot reach the bottom electrode. Therefore, I pea k decrease can be related statistically to the percentage of aptamers interacting with the cell, a process that is thermally activated. Discussion on “cell gravity” signal to noise and temperature effects the present device with suspended cells improves signal to noise ratio as it suppresses the parasitic signal arising from non-target cells (FIGs. 4a, b), clearly pointing out what we can call a “cell gravity” issue. Interestingly, previously reported electrochemical cytosensors (beyond e-DNA sensors) were typically based on a more complex architecture involving several self-assembly steps and nanoparticles.
- nanoparticles once on the surface, are playing a role analogue to the HSQ nanopillars introduced here.
- the nanopillar approach has the merit to simplify the assembly process, to control perfectly z gap , and to be compatible with an aggressive downscaling/integration with many nanoelectrodes. It is also compatible with other nanoelectrochemical sensing approach including the one introduced by ECsens, so far based on biological systems smaller than 2 microns. Future versions of the device will be developed in multiple electrode configurations, thus enabling statistical analysis at the single-cell level, exploiting our single-cell trapping lab-on-chip.
- the actual limit of detection is the nonfaradic capacitance arising from the sensing nanolayer, that is proportional to the active area.
- 13 cells correspond to about 1/1000 of the active area in the present experiment
- the use of sensing area matching exactly to a single-cell with microwells should enable to get high signal to noise ratio at the single-cell level.
- the absolute I pea k value is expected to be in the tens of pA for a single cell, which could be measured with commercial equipment.
- the recent breakthrough in electrochemistry instrumentation allowing CVs at the aA level would be directly beneficial to the present sensing approach, allowing sub-cellular (and potentially single-molecule) studies with nanoelectrodes in the 10 nm-range.
- a second advantage is related to the temperature dependence associated with the confinement effect. These devices aim to be implemented at the single-cell level, providing statistical distributions related to target and non-target cells populations.
- the difference in signal AI pea k is increasing significantly with temperature as I pea k related to non-target cells doesn’t depend on temperature (as opposed to unconfined aptamers).
- FIG.6b illustrates this with a clear change in AI pea k observed at 30 °C, with cells simply inserted in a microfluidic channel without any prior incubation.
- a novel nano-electrochemical biosensor that uses nanopillar arrays to efficiently suppress the issue of cell gravity effect.
- the stability and efficiency of this device is illustrated for the detection of EpCAM expressed in pancreatic cancer cells. Selectivity and sensitivity are illustrated over 3 orders of magnitude.
- the next device generation will be focusing on single-cell and potentially sub-cellular or single-molecule measurements, thereby offering unprecedented statistical analysis for the detection of rare cells such as CTCs.
- Molecular dynamics and experimental data presented here suggest that confinement significantly improves signal to noise ratio and affects aptamers melting temperature. Such an effect is a precious degree of freedom to optimize molecular interactions at near room temperature.
- the Silicon wafer deposited with 20 nm gold/2 nm Ti was cleaned in Acetone with sonication for 5 min, followed by rinsing with Isopropyl alcohol, deionized water and drying with nitrogen gas.
- the cleaned chip was immersed in the freshly prepared solution of 1 mM OEG-SH in pure ethanol (containing an ethylene glycol repeat unit HS(CH2)B(OCH2CH2)6OCH2COOH, purchased from Prochimia) for 1 h and cleaned with ethanol, then immersed in 1 pM ssDNA-Fc solution, i.e., thiolated SYL3C aptamer dissolved in 0.5 M potassium phosphate solution (pH 8) for 2 h to obtain the mixed self-assembled monolayer surface.
- 1 mM OEG-SH in pure ethanol (containing an ethylene glycol repeat unit HS(CH2)B(OCH2CH2)6OCH2COOH, purchased from Prochimia) for 1 h and cleaned with ethanol, then immersed in 1 pM ssDNA-Fc solution, i.e., thiolated SYL3C aptamer dissolved in 0.5 M potassium phosphate solution (pH 8) for 2 h to obtain
- the aptamer sequence was as follows: ferrocene-5'-CAC TAC AGA GGT TGC GTC TGT CCC ACG TTG TCA TGG GGG GTT GGC CTG-(CH 2 ) 3 -3'-SH (purchased from Biomers).
- the density of the probes was estimated to be about 2 x 10 13 aptamers/cm 2 from the CV curves after background subtraction.
- the OEG or PEG backfilling approach is known to drastically reduce biofouling and thus nonspecific protein adsorption.
- the sample was cleaned with a solution of 0.05% Tween 20 for 10 s before use.
- Hydrogen silsesquioxane (HSQ, Dow Coming XR-1541) negative electron beam (e-beam) resist is used to fabricate the nanopillars by using e-beam lithography; in this work the Advantest F7000s-VD02 e-beam machine is used.
- the HSQ resist in a carrier solvent of MIBK was spin-coated on the Au/Ti/Si subtracted with acceleration 5000 rpm for 60 s and then baking at 150 °C for 2 min.
- the cured sample was then loaded in the e-beam machine and was exposed with a dose of 500 pC/cm 2 by using the on the fly (OTF) mode.
- the exposed sample was finally immersed in the alkali developer NMD-3 (TMAH 2.38%) for 5 min and then cured at 150 °C for 5 min to obtain the desired nanopillar array.
- TMAH 2.38% alkali developer NMD-3
- Capan-2 Human Pancreas Adenocarcinoma cell line
- Ramos cells Backitt lymphoma cell line
- Capan-2 and Ramos cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 100 mg/mL penicillin-streptomycin) in a 5% CO2 atmosphere at 37 °C.
- FBS fetal bovine serum
- the cells were collected and separated from the medium by centrifugation at 1000 rpm, 4 °C for 5 min, and then were resuspended in a sterile PBS solution (pH 7.1), to obtain a homogeneous cell suspension.
- the cell suspension was prepared just before incubating with device.
- the cell number and cell size ( Figure 10) were determined using a Petro ff-Hausser Vcell counting chamber.
- the coaxial stacking term captures stacking interactions between bases that are not immediate neighbors along the backbone of a strand. Hydrogen-bonding interactions are possible only between complementary, Crick- Watson (A-T and C-G) base pairs, with the additional condition of approximate antialignment of the phosphodiester linkage, which leads to the formation of double helical structures. Bases and backbones also have excluded volume interactions, as well as backbones interactions.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Capteur comprenant : un substrat ; une électrode étant formée sur au moins une surface du substrat ; un pilier étant formé sur une surface de l'électrode ; et un élément de détection formé sur la surface de l'électrode, et comprenant un aptamère, une longueur de l'aptamère étant plus courte qu'une hauteur du pilier dans une direction perpendiculaire à la surface de l'électrode.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2022/020301 WO2023210026A1 (fr) | 2022-04-26 | 2022-04-26 | Capteur |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2022/020301 WO2023210026A1 (fr) | 2022-04-26 | 2022-04-26 | Capteur |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023210026A1 true WO2023210026A1 (fr) | 2023-11-02 |
Family
ID=88518236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/020301 WO2023210026A1 (fr) | 2022-04-26 | 2022-04-26 | Capteur |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023210026A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012037397A (ja) * | 2010-08-06 | 2012-02-23 | Canon Inc | センサ素子製造方法、センサ素子及び検出方法 |
US20180100188A1 (en) * | 2016-10-07 | 2018-04-12 | Boehringer Ingelheim Vetmedica Gmbh | Analysis system and method for testing a sample |
US20190265236A1 (en) * | 2016-03-30 | 2019-08-29 | Waqas Khalid | Nanostructure array based sensors for electrochemical sensing, capacitive sensing and field-emission sensing |
US20200072825A1 (en) * | 2016-12-09 | 2020-03-05 | Digital Sensing Limited | Electrochemical sensors and methods of use thereof |
US20200087810A1 (en) * | 2016-12-09 | 2020-03-19 | Manufacturing Systems Limited | Apparatus and methods for controlled electrochemical surface modification |
-
2022
- 2022-04-26 WO PCT/JP2022/020301 patent/WO2023210026A1/fr unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012037397A (ja) * | 2010-08-06 | 2012-02-23 | Canon Inc | センサ素子製造方法、センサ素子及び検出方法 |
US20190265236A1 (en) * | 2016-03-30 | 2019-08-29 | Waqas Khalid | Nanostructure array based sensors for electrochemical sensing, capacitive sensing and field-emission sensing |
US20180100188A1 (en) * | 2016-10-07 | 2018-04-12 | Boehringer Ingelheim Vetmedica Gmbh | Analysis system and method for testing a sample |
US20200072825A1 (en) * | 2016-12-09 | 2020-03-05 | Digital Sensing Limited | Electrochemical sensors and methods of use thereof |
US20200087810A1 (en) * | 2016-12-09 | 2020-03-19 | Manufacturing Systems Limited | Apparatus and methods for controlled electrochemical surface modification |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liang et al. | Wafer-scale uniform carbon nanotube transistors for ultrasensitive and label-free detection of disease biomarkers | |
Chu et al. | Concatenated catalytic hairpin assembly/hyperbranched hybridization chain reaction based enzyme-free signal amplification for the sensitive photoelectrochemical detection of human telomerase RNA | |
KR100449615B1 (ko) | 다-배열,다-특이적전기화학발광시험법 | |
Fan et al. | Ultrasensitive photoelectrochemical immunoassay for matrix metalloproteinase-2 detection based on CdS: Mn/CdTe cosensitized TiO2 nanotubes and signal amplification of SiO2@ Ab2 conjugates | |
Nie et al. | Electrochemiluminescence biosensor based on conducting poly (5-formylindole) for sensitive detection of ramos cells | |
Tzouvadaki et al. | Label-free ultrasensitive memristive aptasensor | |
Patolsky et al. | Nanowire sensors for medicine and the life sciences | |
Maehashi et al. | Label-free protein biosensor based on aptamer-modified carbon nanotube field-effect transistors | |
Gao et al. | Enhanced sensing of nucleic acids with silicon nanowire field effect transistor biosensors | |
Squires et al. | A nanopore–nanofiber mesh biosensor to control DNA translocation | |
Chua et al. | Label-free electrical detection of cardiac biomarker with complementary metal-oxide semiconductor-compatible silicon nanowire sensor arrays | |
Zheng et al. | Robust nonenzymatic hybrid nanoelectrocatalysts for signal amplification toward ultrasensitive electrochemical cytosensing | |
Yang et al. | Sudoku-like lab-on-paper cyto-device with dual enhancement of electrochemiluminescence intermediates strategy | |
WO2011017077A2 (fr) | Système détecteur à base de nanocanaux à sensibilité contrôlée | |
Krecmarova et al. | A label-free diamond microfluidic DNA sensor based on active nitrogen-vacancy center charge state control | |
Meng et al. | Light-addressable electrochemical sensors toward spatially resolved biosensing and imaging applications | |
Li et al. | Redox-labelled electrochemical aptasensors with nanosupported cancer cells | |
Peruzzi et al. | Interfacing aptamers, nanoparticles and graphene in a hierarchical structure for highly selective detection of biomolecules in OECT devices | |
Huang et al. | Cerium dioxide-mediated signal “On–Off” by resonance energy transfer on a lab-on-paper device for ultrasensitive detection of lead ions | |
Suryaganesh et al. | Advanced FET-based biosensors—A detailed review | |
JP2012013550A (ja) | 粒子固定用構造体、粒子解析装置、及び解析方法 | |
Pleshakova et al. | Highly sensitive protein detection by biospecific AFM‐based fishing with pulsed electrical stimulation | |
Wang et al. | Light-addressable square wave voltammetry (LASWV) based on a field-effect structure for electrochemical sensing and imaging | |
Lee et al. | Ultrasensitive electrical detection of follicle-stimulating hormone using a functionalized silicon nanowire transistor chemosensor | |
Zhang et al. | Real-Time Monitoring of Exosomes Secretion from Single Cell Using Dual-Nanopore Biosensors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22940298 Country of ref document: EP Kind code of ref document: A1 |